Affinity Asset Advisors »

Kyverna Therapeutics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $586k 120k 4.89
2024-06-30 $1.5M 200k 7.50

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Verona Pharma Sponsored Ads (VRNA)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nuvalent Inc-a (NUVL)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Vera Therapeutics Cl A (VERA)
Nurix Therapeutics (NRIX)

View all positions for Affinity Asset Advisors

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Northpond Ventures
Jpmorgan Chase & Co
Novo A/S
BlackRock
Vanguard Group
Insight Holdings
Millennium Management
Franklin Resources
Mbb Public Markets I
T. Rowe Price Associates
Geode Capital Management
Jacobs Levy Equity Management

View all funds holding Kyverna Therapeutics